Maria Krevvata

2.5k citations
23 papers · 479 indexed · h-index 8
Topics
Multiple Myeloma Research and Treatments (20 papers)Peptidase Inhibition and Analysis (8 papers)Protein Degradation and Inhibitors (7 papers)
Partner nations
United StatesSpainCanada

In The Last Decade

Maria Krevvata

21 papers receiving 472 citations

Peers

Maria Krevvata
Comparison fields: 5 of 37
  • Hematology 422
  • Molecular Biology 288
  • Oncology 263
  • Immunology 72
  • Genetics 66
Replace María-Ángeles Montalbán with:
María-Ángeles Montalbán Spain
Laura Montejano Spain
Luis Palomera Spain
Raquel Jiménez Spain
Joan Bladé Spain
Yoshiaki Kuroda Japan
Cara A. Rosenbaum United States
Mihaela Popa McKiver United States
D Borrego Spain
K. Elias Germany
Maria Krevvata relative to María-Ángeles Montalbán Spain María-Ángeles Montalbán's profile →
Citations per field
00.5×11.6×
María-Ángeles Montalbán · 1×
Citations per year

Countries citing papers authored by Maria Krevvata

Since Specialization
Citations

This map shows the geographic impact of Maria Krevvata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Krevvata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Krevvata more than expected).

Fields of papers citing papers by Maria Krevvata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Krevvata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Krevvata. The network helps show where Maria Krevvata may publish in the future.

Co-authorship network of co-authors of Maria Krevvata

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Krevvata. A scholar is included among the top collaborators of Maria Krevvata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Krevvata. Maria Krevvata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 1
6 5
7 58
8 4
9 0
10 3
11 2
12 158
13 26
14 28
15 26
16 6
17 3
18 28
19 17
20 101

About Maria Krevvata

Maria Krevvata is a scholar working on Hematology, Genetics and Transplantation, having authored 23 papers that have together received 479 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (20 papers), Peptidase Inhibition and Analysis (8 papers) and Protein Degradation and Inhibitors (7 papers). The work is most often cited by research in Hematology (422 citations), Oncology (263 citations) and Genetics (66 citations). Maria Krevvata has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Kihyun Kım, Sonali Trivedi, Jon Ukropec, Ming Qi, P. Joy Ho, Darrell White, Nizar J. Bahlis, Philippe Moreau, Jesús F. San Miguel and Naoki Takezako. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026